TR201714149A2 - A tablet formulation containing ulipristal acetate. - Google Patents

A tablet formulation containing ulipristal acetate. Download PDF

Info

Publication number
TR201714149A2
TR201714149A2 TR2017/14149A TR201714149A TR201714149A2 TR 201714149 A2 TR201714149 A2 TR 201714149A2 TR 2017/14149 A TR2017/14149 A TR 2017/14149A TR 201714149 A TR201714149 A TR 201714149A TR 201714149 A2 TR201714149 A2 TR 201714149A2
Authority
TR
Turkey
Prior art keywords
ulipristal acetate
formulation containing
tablet formulation
containing ulipristal
acetate
Prior art date
Application number
TR2017/14149A
Other languages
Turkish (tr)
Inventor
Kandemi̇rer Ürün
Çi̇fter Ümi̇t
Kocaoğlan Haluk
Original Assignee
Biofarma Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biofarma Ilac Sanayi Ve Ticaret Anonim Sirketi filed Critical Biofarma Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority to TR2017/14149A priority Critical patent/TR201714149A2/en
Priority to PCT/TR2018/050237 priority patent/WO2019059863A1/en
Publication of TR201714149A2 publication Critical patent/TR201714149A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Buluş; cinsel ilişki sonrası acil kontrasepsiyonda kullanılmak üzere birim tablette etken madde Ulipristal Asetat ve en az bir yardımcı madde içeren tablet formunda farmasötik bir formülasyon ile ilgilidir.Meet; It relates to a pharmaceutical formulation in the form of tablets containing the active ingredient Ulipristal Acetate and at least one excipient per unit tablet for use in emergency contraception after sexual intercourse.

TR2017/14149A 2017-09-25 2017-09-25 A tablet formulation containing ulipristal acetate. TR201714149A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TR2017/14149A TR201714149A2 (en) 2017-09-25 2017-09-25 A tablet formulation containing ulipristal acetate.
PCT/TR2018/050237 WO2019059863A1 (en) 2017-09-25 2018-05-16 A tablet formulation comprising ulipristal acetate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2017/14149A TR201714149A2 (en) 2017-09-25 2017-09-25 A tablet formulation containing ulipristal acetate.

Publications (1)

Publication Number Publication Date
TR201714149A2 true TR201714149A2 (en) 2019-04-22

Family

ID=65810490

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2017/14149A TR201714149A2 (en) 2017-09-25 2017-09-25 A tablet formulation containing ulipristal acetate.

Country Status (2)

Country Link
TR (1) TR201714149A2 (en)
WO (1) WO2019059863A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113406230A (en) * 2021-06-17 2021-09-17 河南泰丰生物科技有限公司 Method for measuring dissolution curve of ulipristal acetate solid preparation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103006595B (en) * 2012-12-25 2018-04-06 江苏亚邦爱普森药业有限公司 The method for preparing ulipristal acetate
EP3164134A1 (en) * 2014-07-03 2017-05-10 Laboratoire HRA-Pharma Method for providing regular contraception

Also Published As

Publication number Publication date
WO2019059863A1 (en) 2019-03-28

Similar Documents

Publication Publication Date Title
GT200600445A (en) SOLID PHARMACEUTICAL PRESENTATION FORMS OF ORAL ADMINISTRATION WITH QUICK RELEASE OF THE ACTIVE PRINCIPLE.
CL2016001411A1 (en) Solid pharmaceutical dosage unit of oral disintegration comprising an estetrol component; Preparation method; use for female contraception and in female hormone replacement therapy.
WO2017141104A8 (en) Method for inducing a sustained immune response
JP2015523407A5 (en)
NI201700173A (en) DROSPIRENONE-BASED CONTRACEPTIVES FOR FEMALE PATIENT AFFECTED WITH EXCESS OF WEIGHT
EA201400737A1 (en) DELIVERY SYSTEM ON THE BASIS OF A PELLET SET WITH IMMEDIATE release of an ACTIVE SUBSTANCE
TR201714149A2 (en) A tablet formulation containing ulipristal acetate.
MX2017005163A (en) Onapristone extended-release compositions and methods.
CL2016000183A1 (en) Stable anti-tuberculosis pharmaceutical composition in a form of a redispersible tablet comprising isoniazid granules and rifapentin granules and their preparation process
ECSP16005208A (en) STABLE ANTI-TUBERCULOSIS PHARMACEUTICAL COMPOSITION IN A FORM OF A COATED TABLET INCLUDING ISONIAZID GRANULES AND RIFAPENTINE GRANULES AND THEIR PREPARATION PROCESS
MX2017013643A (en) Tamper-resistant fixed dose combination providing fast release of two drugs from particles and a matrix.
WO2020022976A3 (en) A formulation comprising dexketoprofen
TR201821115A2 (en) PHARMACEUTICAL COMPOSITION CONTAINING MONTELUKAST AND LEVOSETIRIZIN
TR201714150A1 (en) A Pharmaceutical Formulation In Effervescent Tablet Form Containing Cholecalciferol.
MX2020006886A (en) Drug delivery system.
CO2019013645A2 (en) Dropropizine in combination with ambroxol in the dosage form of syrup and tablets
BR112023003572A2 (en) UTIDELONE SOLID ORAL FORMULATION
DOP2013000136A (en) COMPRESSED PHARMACEUTICAL CONTROLLED RELEASE FOR ORAL ADMINISTRATION
TR201722102A2 (en) A Pharmaceutical Product Containing Levodropropizine
PH12020550597A1 (en) Formulation having improved hygroscopic property and dissolution rate comprising telmisartan or its pharmaceutically acceptable salt
UA97982U (en) DRESSING MEDICINE FOR TABLETS
PH12019501607A1 (en) Tapentadol nasal composition
PH12020550456A1 (en) Alcohol-resistant oral pharmaceutical compositions of lorazepam
EA201800197A1 (en) METHOD FOR PRODUCING PHARMACEUTICAL COMPOSITION IN THE FORM OF TABLETS CONTAINING ABIATERONE ACETATE AS ACTIVE SUBSTANCE AND PHARMACEUTICAL COMPOSITION
AR099971A1 (en) UNIT DOSE FORM THAT INCLUDES EMTRICITABINE, TENOFOVIR, DARUNAVIR AND RITONAVIR AND A MONOLITICAL TABLET THAT INCLUDES DARUNAVIR AND RITONAVIR